Company Filing History:
Years Active: 2012
Title: Innovations by Stefan Heitner in Dronabinol Preparation
Introduction
Stefan Heitner is a notable inventor based in Fuerth, Germany. He has made significant contributions to the field of cannabinoid research, particularly in the preparation of dronabinol. His innovative methods have the potential to impact various applications in the pharmaceutical industry.
Latest Patents
Stefan Heitner holds a patent for a method for the preparation of dronabinol. This invention relates to the cyclization of cannabidiol (CBD) to produce Δ9-tetrahydrocannabinol (Δ9-THC). The method is characterized by the use of an organic solvent and a molecular sieve, which enhances the catalytic properties of the reaction. This innovative approach results in a higher yield of Δ9-THC compared to traditional methods that rely solely on Lewis acid catalysts. Heitner's patent represents a significant advancement in cannabinoid synthesis.
Career Highlights
Stefan Heitner is associated with Bionorica AG, a company known for its research and development in herbal medicine. His work at Bionorica AG has allowed him to focus on innovative methods that can lead to more efficient production processes in the pharmaceutical sector. His dedication to research and development has positioned him as a key figure in cannabinoid innovation.
Collaborations
Stefan Heitner has collaborated with Joachim Erler, contributing to the advancement of cannabinoid research. Their partnership has fostered a productive environment for innovation and development in the field.
Conclusion
Stefan Heitner's contributions to the preparation of dronabinol highlight his innovative spirit and dedication to advancing cannabinoid research. His patent represents a significant step forward in the synthesis of cannabinoids, showcasing the potential for improved pharmaceutical applications.